Search

Displaying results 6161 - 6170 of 10000 in total
  1. Drug

    Apple fruit oil

    go.drugbank.com/drugs/DB14355
    Investigational

    Apple fruit oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  2. Drug

    Moringa oleifera leaf

    go.drugbank.com/drugs/DB14362
    Investigational

    Moringa oleifera leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  3. Drug

    Capsicum annuum whole

    go.drugbank.com/drugs/DB14368
    Investigational

    Capsicum annuum whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  4. Drug

    Aspergillus niger var. niger

    go.drugbank.com/drugs/DB10426
    Approved

    Aspergillus niger var. niger extract is used in allergenic testing.

    Mixtures: Number Ten Mold Mixture, Number Ten Mold Mixture
  5. Drug

    Aureobasidium pullulans var. pullutans

    go.drugbank.com/drugs/DB10427
    Approved

    Aureobasidium pullulans var. pullutans extract is used in allergenic testing.

    Mixtures: Number Ten Mold Mixture, Number Ten Mold Mixture
  6. Drug

    Phoma exigua var. exigua

    go.drugbank.com/drugs/DB10440
    Approved

    Phoma exigua var. exigua extract is used in allergenic testing.

  7. Drug

    Alatrofloxacin

    go.drugbank.com/drugs/DB09335
    ApprovedWithdrawn

    It was withdrawn from the U.S. market in 2001.

  8. Drug

    Aniline

    go.drugbank.com/drugs/DB06728
    Investigational

    Aniline, phenylamine or aminobenzene is an organic compound with the formula C6H5NH2. Consisting of an amine attached to a benzene ring, aniline is the prototypical aromatic amine. … Aniline is colorless, but it slowly oxidizes and resinifies in air, giving a red-brown tint to aged samples.

  9. Drug

    IRX-2

    go.drugbank.com/drugs/DB05643
    Investigational

    It is being investigated to promote or enhance an anti-cancer immune response.

  10. Drug

    CX-046684

    go.drugbank.com/drugs/DB19414
    Approved

    CX-046684 is a COVID-19 mRNA vaccine encoding the pre-fusion stabilized Spike glycoprotein (S) of the SARS-CoV-2 Omicron variant lineage KP.2. It is the active ingredient of the 2024-2025 formulation of Moderna's Spikevax vaccine.